Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | GBA2 | Q9HCG7 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | DPP4 | P27487 | 4/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32681452 | 1.00 | LMNA (0.44) | LMNAPOLBSMN1; SMN2GBA2L3MBTL1 | |
| SCHEMBL9275749 | 0.95 | SMN1; SMN2 (0.43) | LMNAPOLBSMN1; SMN2GBA2L3MBTL1 | |
| SCHEMBL9769183 | 0.94 | GBA2 (0.48) | LMNAPOLBSMN1; SMN2GBA2L3MBTL1 | |
| SCHEMBL27919865 | 0.88 | HPGD (0.42) | LMNAPOLBSMN1; SMN2GBA2L3MBTL1 | |
| SCHEMBL6207726 | 0.86 | LMNA (0.40) | LMNAPOLBSMN1; SMN2GBA2L3MBTL1 | |
| SCHEMBL12133179 | 0.85 | RAB9A (0.43) | POLBL3MBTL1ATMRAB9AALDH1A1 | |
| SCHEMBL13532420 | 0.85 | RAB9A (0.43) | POLBL3MBTL1ATMRAB9AALDH1A1 | |
| SCHEMBL30485004 | 0.83 | ATM (0.43) | LMNAPOLBSMN1; SMN2GBA2L3MBTL1 | |
| SCHEMBL6248598 | 0.82 | SMN1; SMN2 (0.44) | LMNAPOLBSMN1; SMN2GBA2L3MBTL1 | |
| SCHEMBL2731646 | 0.81 | POLB (0.46) | LMNAPOLBSMN1; SMN2GBA2L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023067354-A1 | HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER | ARTIOS PHARMA LIMITED (GB) | 2023-04-27 | — | — | WO | disclosed |
| WO-2021111351-A1 | NOVEL SUBSTITUTED SULFONYLUREA AND SULFOXIMINEUREA DERIVATIVES | CADILA HEALTHCARE LIMITED (IN) | 2021-06-10 | — | — | WO | disclosed |
| EP-3256466-A1 | 1-HETEROCYCLYL ISOCHROMANYL COMPOUNDS AND ANALOGS FOR TREATING CNS DISORDERS | Sunovion Pharmaceuticals Inc. (US) | 2017-12-20 | — | — | EP | disclosed |
| WO-2016130796-A1 | 1-HETEROCYCLYL ISOCHROMANYL COMPOUNDS AND ANALOGS FOR TREATING CNS DISORDERS | SUNOVION PHARMACEUTICALS INC. (US) | 2016-08-18 | — | — | WO | disclosed |
| EP-2632261-A1 | INHIBITORS OF HEPATITIS C VIRUS | Presidio Pharmaceuticals, Inc. (US) | 2013-09-04 | — | — | EP | disclosed |
| WO-2012058125-A1 | INHIBITORS OF HEPATITIS C VIRUS | PRESIDIO PHARMACEUTICALS, INC. (US) | 2012-05-03 | — | — | WO | disclosed |
| EP-1899335-A1 | PYRROLOQUINOLINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS | PIERRE FABRE MEDICAMENT (FR) | 2008-03-19 | — | — | EP | disclosed |
| WO-2007003611-A1 | PYRROLOQUINOLINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS | PIERRE FABRE MEDICAMENT (FR) | 2007-01-11 | — | — | WO | disclosed |